keine Finanzberatung

SYK · Stryker Corporation

Orthopedic implants, surgical robotics and hospital equipment

Risiko 3/10 · LOW-MODERATE RISK · medtech compounder · $303.13 ▼ 1.58%Von KI geschrieben

Stand der Zahlen: · Quellen: öffentliche Markt-Aggregatoren

Kennzahlen

  • Price $303.13
  • Market cap $116.3B
  • P/E (ttm) 31.45
  • Div yield 1.16%
  • 52-wk range $281.00 – $395.90
  • Index rank #95 / —

Wichtigste Risiken

  • Input-cost and tariff pressure squeezing margins (Shareholders) — MED
  • Premium multiple punishes any execution miss (Q1 showed how) (Shareholders) — MED
  • Hospital capex or procedure-volume slowdown (Shareholders) — MED
  • Heavy insider selling with zero buying over six months (Shareholders) — LOW

Fazit

A genuine quality compounder, but you are paying compounder prices while costs are still biting — buy the business, not the momentum.

Interaktive Analyse öffnen →

Recherche, keine Anlageberatung.

⚠️ Independent research for a video, not financial advice. Figures from public sources/aggregators, can be stale; risk scores are editorial estimates. Verify before relying on any of it.